UMIN ID: UMIN000002012
Registered date:30/04/2010
Evaluation of pegaptanib and ranibizumab for macular edema secondary to retinal vein occlusion
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | macular edema secondary to retinal vein occlusion |
Date of first enrollment | 2009/04/01 |
Target sample size | 20 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Intravitreal pegaptanib for treatment Intravitreal ranibizumab for treatment |
Outcome(s)
Primary Outcome | visual acuity,foveal thickness |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | 20years-old |
---|---|
Age maximum | 90years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | The patients with good visual acuity |
Related Information
Primary Sponsor | Yamagata university,Faculty of Medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Yamagata university,Faculty of Medicine |
Secondary ID(s) |
Contact
public contact | |
Name | |
Address | 2-2-2iidanishi,Yamagata city Japan |
Telephone | 023-628-5374 |
Affiliation | Yamagata university,Faculty of Medicine Department of Ophthalmology |
scientific contact | |
Name | Hidetoshi Yamashita |
Address | 2-2-2iidanishi,Yamagata city Japan |
Telephone | 023-628-5374 |
Affiliation | Yamagata university,Faculty of Medicine Department of Ophthalmology |